Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19
Eric A. Meyerowitz, Augustin Vannier, Morgan G. N. Friesen, et al.
The FASEB Journal (2020) Vol. 34, Iss. 5, pp. 6027-6037
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19
Francis K. Yoshimoto
The Protein Journal (2020) Vol. 39, Iss. 3, pp. 198-216
Open Access | Times Cited: 549
Inoculating Against Fake News About COVID-19
Sander van der Linden, Jon Roozenbeek, Josh Compton
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 494
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
Effat Davoudi-Monfared, Hamid Rahmani, Hossein Khalili, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 9
Open Access | Times Cited: 287
Review article: COVID‐19 and liver disease—what we know on 1st May 2020
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 2, pp. 267-275
Open Access | Times Cited: 217
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
Sebastiano Cicco, Gerolamo Cicco, Vito Racanelli, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-25
Open Access | Times Cited: 165
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Zakariya Kashour, Muhammad Riaz, Musa A. Garbati, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 1, pp. 30-42
Open Access | Times Cited: 125
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
Sairaj Satarker, Tejas Ahuja, Madhuparna Banerjee, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 5, pp. 203-211
Open Access | Times Cited: 105
Possibility of magnesium supplementation for supportive treatment in patients with COVID-19
Chuanfeng Tang, Hong Ding, Rui‐Qing Jiao, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173546-173546
Open Access | Times Cited: 105
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
Pankaj Bansal, Amandeep Goyal, Austin Cusick, et al.
Annals of Medicine (2020) Vol. 53, Iss. 1, pp. 117-134
Open Access | Times Cited: 91
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
Amin Gasmi, Massimiliano Peana, Sàdaf Noor, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 4, pp. 1333-1343
Open Access | Times Cited: 84
Addressing Africa’s pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa
Hassan Hussein Musa, Taha Hussein Musa, Idriss Hussein Musa, et al.
International Journal of Infectious Diseases (2020) Vol. 102, pp. 483-488
Open Access | Times Cited: 77
Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak
Mohammad Mahfuz Ali Khan Shawan, Sajal Kumar Halder, Md. Ashraful Hasan
Bulletin of the National Research Centre/Bulletin of the National Research Center (2021) Vol. 45, Iss. 1
Open Access | Times Cited: 72
Immunomodulatory Drugs in the Management of SARS-CoV-2
Daniel Burrage, Soraya Koushesh, Nidhi Sofat
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 70
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1759-1759
Open Access | Times Cited: 56
Role of Autophagy in Lung Inflammation
Jacob D. Painter, Lauriane Galle-Treger, Omid Akbari
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 64
Coagulopathy in COVID-19: Focus on vascular thrombotic events
Wei Shi, Jiagao Lv, Li Lin
Journal of Molecular and Cellular Cardiology (2020) Vol. 146, pp. 32-40
Open Access | Times Cited: 61
SARS-CoV-2: Targeted managements and vaccine development
Moiz Bakhiet, Sébastien Taurin
Cytokine & Growth Factor Reviews (2020) Vol. 58, pp. 16-29
Open Access | Times Cited: 58
Taming the Autophagy as a Strategy for Treating COVID-19
Blanca Estela García‐Pérez, Juan Antonio González-Rojas, Ma Isabel Salazar, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2679-2679
Open Access | Times Cited: 57
A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Teodoro J. Oscanoa, Román Romero‐Ortuño, Alfonso Carvajal, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 3, pp. 106078-106078
Open Access | Times Cited: 52
Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study
Fahad Faqihi, Abdulrahman Alharthy, Mohammed A. Al-Odat, et al.
Journal of Critical Care (2020) Vol. 60, pp. 328-333
Open Access | Times Cited: 51
Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity
Stephen L. Sturley, Tamayanthi Rajakumar, Natalie Hammond, et al.
Journal of Lipid Research (2020) Vol. 61, Iss. 7, pp. 972-982
Open Access | Times Cited: 49
A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients
Abu Taiub Mohammed Mohiuddin Chowdhury
Eurasian Journal of Medicine and Oncology (2021)
Open Access | Times Cited: 40
Comprehensive in-vitro antibacterial and in-silico anti-viral evaluations of selected fluorinated-quinolone ligands and their Ag/Zn-based coordination polymers
Amina Boughougal, Filippo Monti, Abdenour Guerraoui, et al.
Journal of Molecular Structure (2025), pp. 141280-141280
Closed Access
SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
Cristina Dehelean, Voichița Elena Lăzureanu, Dorina Coricovac, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2084-2084
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top